These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9742874)

  • 1. [Problem in prolonged levodopa administration of Parkinson disease patients--from the standpoint of the autonomic nervous function].
    Matsui TA; Nishikawa S; Saigo K; Kihara M; Takahashi M
    Rinsho Shinkeigaku; 1998 Apr; 38(4):295-300. PubMed ID: 9742874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of advanced Parkinson's disease].
    Momose Y; Murata M; Kanazawa I
    Nihon Rinsho; 2000 Oct; 58(10):2061-5. PubMed ID: 11068447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
    Nyholm D; Jansson R; Willows T; Remahl IN
    Neurology; 2005 Nov; 65(9):1506-7. PubMed ID: 16275852
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
    Nutt JG
    Neurology; 2006 May; 66(10):1611-2; author reply 1611-2. PubMed ID: 16717244
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.
    Avanzi M; Uber E; Bonfà F
    Neurol Sci; 2004 Jun; 25(2):98-101. PubMed ID: 15221629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of L-dopa therapy.
    Bouhaddi M; Vuillier F; Fortrat JO; Cappelle S; Henriet MT; Rumbach L; Regnard J
    Auton Neurosci; 2004 Nov; 116(1-2):30-8. PubMed ID: 15556835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomic nervous function in de novo parkinsonian patients in basal condition and after acute levodopa administration.
    Quadri R; Comino I; Scarzella L; Cacioli P; Zanone MM; Pipieri A; Bergamasco B; Chiandussi L
    Funct Neurol; 2000; 15(2):81-6. PubMed ID: 10916719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [L-dopa effectiveness decreases over time. What helps Parkinson patients stay mobile?].
    Wedekind S
    MMW Fortschr Med; 2005 Jun; 147(22):10. PubMed ID: 15977622
    [No Abstract]   [Full Text] [Related]  

  • 9. [Multivariate analysis of the problems of long-term levodopa therapy in Parkinson's disease].
    Nakamura Y; Yoshinaga J; Endo S; Hikiji A
    Rinsho Shinkeigaku; 1997 Jun; 37(6):469-75. PubMed ID: 9366172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Belly dystonia induced by levodopa and biperiden in a case of suspected multiple-system atrophy.
    Shan DE; Kwan SY; Ho HH; Su MS
    Mov Disord; 1996 Jul; 11(4):455-7. PubMed ID: 8813234
    [No Abstract]   [Full Text] [Related]  

  • 11. Orthostatic heart rate variability analysis in idiopathic Parkinson's disease.
    Mihci E; Kardelen F; Dora B; Balkan S
    Acta Neurol Scand; 2006 May; 113(5):288-93. PubMed ID: 16629763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Utility of the study of the vegetative nervous system in the differential diagnosis between Parkinson's disease and multiple system atrophy].
    Rouco I; Gómez JC; Lezcano E; Aniel-Quiroga MA; Velasco F; Barcena J; Pérez Bas M; Hurtado P; Cruz Lachén M; Zarranz JJ
    Neurologia; 2006 Apr; 21(3):119-23. PubMed ID: 16575624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of early selegiline therapy on long-term levodopa treatment and parkinsonian disability: an interim analysis of a Norwegian--Danish 5-year study. Norwegian-Danish Study Group.
    Larsen JP; Boas J
    Mov Disord; 1997 Mar; 12(2):175-82. PubMed ID: 9087975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys.
    Blanchet PJ; Konitsiotis S; Chase TN
    Mov Disord; 1998 Sep; 13(5):798-802. PubMed ID: 9756148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort Investigators
    Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
    Nyholm D; Nilsson Remahl AI; Dizdar N; Constantinescu R; Holmberg B; Jansson R; Aquilonius SM; Askmark H
    Neurology; 2005 Jan; 64(2):216-23. PubMed ID: 15668416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relation between autonomic dysfunction and progression of Parkinson's disease].
    Oka H; Mochio S; Inoue K
    Rinsho Shinkeigaku; 2001 Jun; 41(6):283-8. PubMed ID: 11771156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
    Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
    Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral stimulation of nucleus subthalamicus in advanced Parkinson's disease: no effects on, and of, autonomic dysfunction.
    Holmberg B; Corneliusson O; Elam M
    Mov Disord; 2005 Aug; 20(8):976-81. PubMed ID: 15858814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.